An observational, multicenter study to evaluate the safety and tolerability of deferasirox in the treatment of pediatric patients with non-transfusion-dependent iron overload (NESO)First published 28/02/2014 Last updated 03/02/2025 EU PAS number: EUPAS5914StudyOngoing